Literature DB >> 2095322

The role of pneumolysin in ocular infections with Streptococcus pneumoniae.

M K Johnson1, J A Hobden, M Hagenah, R J O'Callaghan, J M Hill, S Chen.   

Abstract

Pneumolysin, a cytolytic protein produced by Streptococcus pneumoniae, has many properties which suggest it may be an important virulence factor in pneumococcal ocular infections. To directly test this possibility, we have constructed pneumolysin-negative strains of S. pneumoniae and compared their virulence with that of the wild type in a rabbit model of intracorneal infection. A pneumolysin-negative strain produced by chemical mutagenesis (probably a point mutant) was found to be no less virulent than the parent strain. However, a strain bearing a deletion in the pneumolysin gene showed greatly reduced virulence. This strain produced less pathology while showing significantly higher bacterial counts. These results suggest that a property of the pneumolysin molecule other than its cytolytic (hemolytic) activity may be involved in its pathogenic mechanism of action. This property may be the ability to activate complement, known to be a function of pneumolysin, which results in influx of PMNs, reducing the bacterial counts but also producing tissue damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095322     DOI: 10.3109/02713689008997584

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  29 in total

1.  Effectiveness of antimicrobial peptide immobilization for preventing perioperative cornea implant-associated bacterial infection.

Authors:  Xiao Wei Tan; Tze Wei Goh; P Saraswathi; Chan Lwin Nyein; Melina Setiawan; Andri Riau; R Lakshminarayanan; Shouping Liu; Donald Tan; Roger W Beuerman; Jodhbir S Mehta
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

3.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

4.  Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

Authors:  Melissa E Sanders; Nathan A Tullos; Sidney D Taylor; Erin W Norcross; Lauren B King; Isaiah Tolo; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-12       Impact factor: 2.424

5.  The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

Authors:  F E Perry; J R Catterall
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

6.  Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.

Authors:  M C Callegan; L S Engel; J M Hill; R J O'Callaghan
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.

Authors:  Emilia Ghelardi; Arianna Tavanti; Paola Davini; Francesco Celandroni; Sara Salvetti; Eva Parisio; Enrico Boldrini; Sonia Senesi; Mario Campa
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Development of a Streptococcus pneumoniae keratitis model in mice.

Authors:  Quincy C Moore; Clare C McCormick; Erin W Norcross; Chinwendu Onwubiko; Melissa E Sanders; Jonathan Fratkin; Larry S McDaniel; Richard J O'Callaghan; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2009-07-23       Impact factor: 2.892

9.  Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.

Authors:  J A Hobden; J M Hill; L S Engel; R J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Toxicity of pneumolysin to pulmonary alveolar epithelial cells.

Authors:  J B Rubins; P G Duane; D Clawson; D Charboneau; J Young; D E Niewoehner
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.